Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma
Abstract To identify risk factors for infection in patients with diffuse large B cell lymphoma (DLBCL) undergoing rituximab, cyclophosphamide, vincristine, adriamycin and prednisolone (R-CHOP) treatment. All patients with DLBCL who received R-CHOP from 2004–2014 in a tertiary Australian hospital wer...
Main Authors: | Claire Dendle, Michael Gilbertson, Tim Spelman, Rhonda L. Stuart, Tony M. Korman, Karin Thursky, Stephen Opat, Zoe McQuilten |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-06-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-04495-x |
Similar Items
-
Disseminated Enteroviral Infection Associated with Obinutuzumab
by: Claire Dendle, et al.
Published: (2015-09-01) -
Platelet storage duration and its clinical and transfusion outcomes: a systematic review
by: Cécile Aubron, et al.
Published: (2018-08-01) -
Transfusion of stored platelets: balancing risks and product availability
by: Aubron C, et al.
Published: (2016-11-01) -
Improving patient safety by doing less rather than more: many peripheral intravenous catheters are unnecessary
by: Egerton-Warburton, Diana, et al.
Published: (2014-03-01) -
Infection with Scedosporium apiospermum and S. prolificans, Australia
by: Louise Cooley, et al.
Published: (2007-08-01)